Fifty years after Bruce Chatwin embarked on his ‘peculiar, dotty’ bestseller, the South American wilderness still calls ...

"The strong global launch of YORVIPATH positions 2025 to ... of clinical activity in platinum-resistant ovarian cancer. Financial Update As of March 31, 2025, Ascendis Pharma had cash and cash ...

Enrolled the last participant in the large, global ... Chief Financial Officer, Henriette Wennicke; Chief Medical Officer, David Kendall; and Chief Commercial Officer, Eric Cox. The conference call ...

Format: Presentation and one-on-one investor meetings Presentation Time: 4:55 p.m. ET Corbus Pharmaceuticals Holdings, Inc.

Chief Financial Officer of NewAmsterdam Pharma, will participate in a fireside chat at the 2025 RBCCM Global Healthcare Conference on Tuesday, May 20, 2025 at 10:00 a.m. ET. A live webcast of the ...

Ascendis Pharma will host a conference call and webcast today at 4:30 pm Eastern Time (ET) to discuss its first quarter 2025 financial results. Ascendis Pharma is a global biopharmaceutical ...

"Our business momentum continued in the first quarter of 2025 as we delivered double-digit growth in Portfolio Receipts and raised our financial guidance ... cap biotechnology companies to leading ...

The latest iteration of the police dog is the robotic K9, used to assess potentially dangerous scenes before entering. These ...

NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of ...

Revenue from global sales of IMCIVREE (setmelanotide ... or a net loss per basic and diluted share of ($2.35). Financial Guidance: For the year ending December 31, 2025, Rhythm anticipates ...

May 09, 2025 (GLOBE NEWSWIRE) -- Athira Pharma ... its financial condition and the sufficiency of its cash, cash equivalents and investments to fund its planned operations may be incorrect; adverse ...